Physician profile
Richard Layfield
NPI 1326133893
$4,924.95
in general payments reported to CMS, 2019-2025
13 companies · $98.15 in 2025
The $98.15 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,288 · 2020: $128 · 2021: $1,301 · 2022: $1,763 · 2023: $96.62 · 2024: $250 · 2025: $98.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $2,442.97 | 2021-2025 | |
| Depuy Synthes Products, INC. | $1,350.00 | 2019-2022 | |
| Medtronic, INC. | $262.97 | 2021-2024 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $215.29 | 2020-2024 | Fast-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium, Ultrabutton |
| Djo, LLC | $174.68 | 2019 | |
| Depuy Synthes Sales INC. | $127.35 | 2020-2025 | Truespan Orthocord, Orthocord, Rigidfix |
| Medtronic USA, INC. | $118.30 | 2019 | |
| Stryker Corporation | $90.53 | 2019-2021 | |
| Medical Device Business Services, INC. | $76.30 | 2019 | |
| Fidia Pharma USA INC. | $38.82 | 2025 | Hymovis |
| Zimmer Biomet Holdings, INC. | $16.57 | 2021 | |
| Stimwave Technologies Incorporated | $11.17 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$91,736.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Layfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.